Concepedia

Richard Lee

RL

Statistics

Publications

72

Citations

8.8K

H-Index

47

Active since

1996

Affiliations

Ionis Pharmaceuticals (United States)(Current)

University of California, Los Angeles

Wake Forest University

Cleveland Clinic

AstraZeneca (Sweden)

Richard Lee is an author at Ionis Pharmaceuticals (United States) specializing in life sciences, lipid metabolism, and biochemistry.

ORCID

Publications per year

1996–2025

72

Publications

72

Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation

Brian J. Bennett, Thomas Q. de Aguiar Vallim, Zeneng Wang et al. · Cell Metabolism · 2013 · 1.1K citations · Full text

, , +14

Cardiovascular and Metabolic Effects of <i>ANGPTL3</i> Antisense Oligonucleotides

Mark J. Graham, Richard Lee, Teresa Brandt et al. · New England Journal of Medicine · 2017 · 581 citations · Full text

, , +14

The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance

Manya Warrier, Diana M. Shih, Amy Burrows et al. · Cell Reports · 2015 · 416 citations · Full text

, , +17

Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans

Mark J. Graham, Richard Lee, Thomas A. Bell et al. · Circulation Research · 2013 · 372 citations · Full text

, , +14

Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis

Diana M. Shih, Zeneng Wang, Richard Lee et al. · Journal of Lipid Research · 2014 · 339 citations · Full text

, , +15

1–5 of 72